Yasin Memari
Wellcome Trust Sanger Institute
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Yasin Memari.
Nature Communications | 2015
Jie Huang; Bryan Howie; Shane McCarthy; Yasin Memari; Klaudia Walter; Jl Min; Petr Danecek; Giovanni Malerba; Elisabetta Trabetti; Hou-Feng Zheng; Giovanni Gambaro; Jb Richards; Richard Durbin; Nj Timpson; Jonathan Marchini; Nicole Soranzo
Imputing genotypes from reference panels created by whole-genome sequencing (WGS) provides a cost-effective strategy for augmenting the single-nucleotide polymorphism (SNP) content of genome-wide arrays. The UK10K Cohorts project has generated a data set of 3,781 whole genomes sequenced at low depth (average 7x), aiming to exhaustively characterize genetic variation down to 0.1% minor allele frequency in the British population. Here we demonstrate the value of this resource for improving imputation accuracy at rare and low-frequency variants in both a UK and an Italian population. We show that large increases in imputation accuracy can be achieved by re-phasing WGS reference panels after initial genotype calling. We also present a method for combining WGS panels to improve variant coverage and downstream imputation accuracy, which we illustrate by integrating 7,562 WGS haplotypes from the UK10K project with 2,184 haplotypes from the 1000 Genomes Project. Finally, we introduce a novel approximation that maintains speed without sacrificing imputation accuracy for rare variants.
Nature | 2017
Helena Kilpinen; Angela Goncalves; Andreas Leha; Vackar Afzal; Kaur Alasoo; Sofie Ashford; Sendu Bala; Dalila Bensaddek; Francesco Paolo Casale; Oliver J. Culley; Petr Danecek; Adam Faulconbridge; Peter W. Harrison; Annie Kathuria; Davis J. McCarthy; Shane McCarthy; Ruta Meleckyte; Yasin Memari; Nathalie Moens; Filipa Soares; Alice L. Mann; Ian Streeter; Chukwuma A. Agu; Alex Alderton; Rachel Nelson; Sarah Harper; Minal Patel; Alistair White; Sharad R Patel; Laura Clarke
Technology utilizing human induced pluripotent stem cells (iPS cells) has enormous potential to provide improved cellular models of human disease. However, variable genetic and phenotypic characterization of many existing iPS cell lines limits their potential use for research and therapy. Here we describe the systematic generation, genotyping and phenotyping of 711 iPS cell lines derived from 301 healthy individuals by the Human Induced Pluripotent Stem Cells Initiative. Our study outlines the major sources of genetic and phenotypic variation in iPS cells and establishes their suitability as models of complex human traits and cancer. Through genome-wide profiling we find that 5–46% of the variation in different iPS cell phenotypes, including differentiation capacity and cellular morphology, arises from differences between individuals. Additionally, we assess the phenotypic consequences of genomic copy-number alterations that are repeatedly observed in iPS cells. In addition, we present a comprehensive map of common regulatory variants affecting the transcriptome of human pluripotent cells.
Nature Communications | 2014
Nicholas J. Timpson; Klaudia Walter; Josine L. Min; Ioanna Tachmazidou; Giovanni Malerba; So-Youn Shin; Lu Chen; Marta Futema; Lorraine Southam; Valentina Iotchkova; Massimiliano Cocca; Jie Huang; Yasin Memari; Shane McCarthy; Petr Danecek; Dawn Muddyman; Massimo Mangino; Cristina Menni; John Perry; Susan M. Ring; Amadou Gaye; George Dedoussis; Aliki-Eleni Farmaki; Paul R. Burton; Philippa J. Talmud; Giovanni Gambaro; Tim D. Spector; George Davey Smith; Richard Durbin; J. Brent Richards
The analysis of rich catalogues of genetic variation from population-based sequencing provides an opportunity to screen for functional effects. Here we report a rare variant in APOC3 (rs138326449-A, minor allele frequency ~0.25% (UK)) associated with plasma triglyceride (TG) levels (−1.43 s.d. (s.e.=0.27 per minor allele (P-value=8.0 × 10−8)) discovered in 3,202 individuals with low read-depth, whole-genome sequence. We replicate this in 12,831 participants from five additional samples of Northern and Southern European origin (−1.0 s.d. (s.e.=0.173), P-value=7.32 × 10−9). This is consistent with an effect between 0.5 and 1.5 mmol l−1 dependent on population. We show that a single predicted splice donor variant is responsible for association signals and is independent of known common variants. Analyses suggest an independent relationship between rs138326449 and high-density lipoprotein (HDL) levels. This represents one of the first examples of a rare, large effect variant identified from whole-genome sequencing at a population scale.
Nature Communications | 2016
Lindsey Van Haute; Sabine Dietmann; Laura S. Kremer; Shobbir Hussain; Sarah F. Pearce; Christopher A. Powell; Joanna Rorbach; Rebecca Lantaff; Sandra Blanco; Sascha Sauer; Urania Kotzaeridou; Georg F. Hoffmann; Yasin Memari; Anja Kolb-Kokocinski; Richard Durbin; Johannes A. Mayr; Michaela Frye; Holger Prokisch; Michal Minczuk
Epitranscriptome modifications are required for structure and function of RNA and defects in these pathways have been associated with human disease. Here we identify the RNA target for the previously uncharacterized 5-methylcytosine (m5C) methyltransferase NSun3 and link m5C RNA modifications with energy metabolism. Using whole-exome sequencing, we identified loss-of-function mutations in NSUN3 in a patient presenting with combined mitochondrial respiratory chain complex deficiency. Patient-derived fibroblasts exhibit severe defects in mitochondrial translation that can be rescued by exogenous expression of NSun3. We show that NSun3 is required for deposition of m5C at the anticodon loop in the mitochondrially encoded transfer RNA methionine (mt-tRNAMet). Further, we demonstrate that m5C deficiency in mt-tRNAMet results in the lack of 5-formylcytosine (f5C) at the same tRNA position. Our findings demonstrate that NSUN3 is necessary for efficient mitochondrial translation and reveal that f5C in human mitochondrial RNA is generated by oxidative processing of m5C.
Nature Communications | 2015
Peter N. Taylor; Eleonora Porcu; Shelby Chew; Purdey J. Campbell; Michela Traglia; Suzanne J. Brown; Benjamin H. Mullin; Hashem A. Shihab; Josine Min; Klaudia Walter; Yasin Memari; Jie Huang; Michael R. Barnes; John Beilby; Pimphen Charoen; Petr Danecek; Frank Dudbridge; Vincenzo Forgetta; Celia M. T. Greenwood; Elin Grundberg; Andrew D. Johnson; Jennie Hui; Ee Mun Lim; Shane McCarthy; Dawn Muddyman; Vijay Panicker; John Perry; Jordana T. Bell; Wei Yuan; Caroline L Relton
Normal thyroid function is essential for health, but its genetic architecture remains poorly understood. Here, for the heritable thyroid traits thyrotropin (TSH) and free thyroxine (FT4), we analyse whole-genome sequence data from the UK10K project (N=2,287). Using additional whole-genome sequence and deeply imputed data sets, we report meta-analysis results for common variants (MAF≥1%) associated with TSH and FT4 (N=16,335). For TSH, we identify a novel variant in SYN2 (MAF=23.5%, P=6.15 × 10−9) and a new independent variant in PDE8B (MAF=10.4%, P=5.94 × 10−14). For FT4, we report a low-frequency variant near B4GALT6/SLC25A52 (MAF=3.2%, P=1.27 × 10−9) tagging a rare TTR variant (MAF=0.4%, P=2.14 × 10−11). All common variants explain ≥20% of the variance in TSH and FT4. Analysis of rare variants (MAF<1%) using sequence kernel association testing reveals a novel association with FT4 in NRG1. Our results demonstrate that increased coverage in whole-genome sequence association studies identifies novel variants associated with thyroid function.
American Journal of Respiratory Cell and Molecular Biology | 2015
Adrien Frommer; Rim Hjeij; Niki T. Loges; Christine Edelbusch; Charlotte Jahnke; Johanna Raidt; Claudius Werner; Julia Wallmeier; Jörg Große-Onnebrink; Heike Olbrich; Sandra Cindrić; Martine Jaspers; Mieke Boon; Yasin Memari; Richard Durbin; Anja Kolb-Kokocinski; Sascha Sauer; June K. Marthin; Kim G. Nielsen; Israel Amirav; Nael Elias; Eitan Kerem; David Shoseyov; Karsten Haeffner; Heymut Omran
Primary ciliary dyskinesia (PCD) is a genetically heterogeneous recessive disorder caused by several distinct defects in genes responsible for ciliary beating, leading to defective mucociliary clearance often associated with randomization of left/right body asymmetry. Individuals with PCD caused by defective radial spoke (RS) heads are difficult to diagnose owing to lack of gross ultrastructural defects and absence of situs inversus. Thus far, most mutations identified in human radial spoke genes (RSPH) are loss-of-function mutations, and missense variants have been rarely described. We studied the consequences of different RSPH9, RSPH4A, and RSPH1 mutations on the assembly of the RS complex to improve diagnostics in PCD. We report 21 individuals with PCD (16 families) with biallelic mutations in RSPH9, RSPH4A, and RSPH1, including seven novel mutations comprising missense variants, and performed high-resolution immunofluorescence analysis of human respiratory cilia. Missense variants are frequent genetic defects in PCD with RS defects. Absence of RSPH4A due to mutations in RSPH4A results in deficient axonemal assembly of the RS head components RSPH1 and RSPH9. RSPH1 mutant cilia, lacking RSPH1, fail to assemble RSPH9, whereas RSPH9 mutations result in axonemal absence of RSPH9, but do not affect the assembly of the other head proteins, RSPH1 and RSPH4A. Interestingly, our results were identical in individuals carrying loss-of-function mutations, missense variants, or one amino acid deletion. Immunofluorescence analysis can improve diagnosis of PCD in patients with loss-of-function mutations as well as missense variants. RSPH4A is the core protein of the RS head.
Annals of clinical and translational neurology | 2015
Tobias B. Haack; Christopher B. Jackson; Kei Murayama; Laura S. Kremer; André Schaller; Urania Kotzaeridou; Maaike C. de Vries; Gudrun Schottmann; Saikat Santra; Boriana Büchner; Thomas Wieland; Elisabeth Graf; Peter Freisinger; Seila Eggimann; Akira Ohtake; Yasushi Okazaki; Masakazu Kohda; Yoshihito Kishita; Yoshimi Tokuzawa; Sascha Sauer; Yasin Memari; Anja Kolb-Kokocinski; Richard Durbin; Oswald Hasselmann; Kirsten Cremer; Beate Albrecht; Dagmar Wieczorek; Hartmut Engels; Dagmar Hahn; Alexander M. Zink
Short‐chain enoyl‐CoA hydratase (ECHS1) is a multifunctional mitochondrial matrix enzyme that is involved in the oxidation of fatty acids and essential amino acids such as valine. Here, we describe the broad phenotypic spectrum and pathobiochemistry of individuals with autosomal‐recessive ECHS1 deficiency.
Nature Genetics | 2016
Valentina Iotchkova; Jie Huang; John A. Morris; Deepti Jain; Caterina Barbieri; Klaudia Walter; Josine L. Min; Lu Chen; William Astle; Massimilian Cocca; Patrick Deelen; Heather Elding; Aliki-Eleni Farmaki; Christopher S. Franklin; Tom R. Gaunt; Albert Hofman; Tao Jiang; Marcus E. Kleber; Genevieve Lachance; Jian'an Luan; Giovanni Malerba; Angela Matchan; Daniel Mead; Yasin Memari; Ioanna Ntalla; Kalliope Panoutsopoulou; Raha Pazoki; John Perry; Fernando Rivadeneira; Maria Sabater-Lleal
Large-scale whole-genome sequence data sets offer novel opportunities to identify genetic variation underlying human traits. Here we apply genotype imputation based on whole-genome sequence data from the UK10K and 1000 Genomes Project into 35,981 study participants of European ancestry, followed by association analysis with 20 quantitative cardiometabolic and hematological traits. We describe 17 new associations, including 6 rare (minor allele frequency (MAF) < 1%) or low-frequency (1% < MAF < 5%) variants with platelet count (PLT), red blood cell indices (MCH and MCV) and HDL cholesterol. Applying fine-mapping analysis to 233 known and new loci associated with the 20 traits, we resolve the associations of 59 loci to credible sets of 20 or fewer variants and describe trait enrichments within regions of predicted regulatory function. These findings improve understanding of the allelic architecture of risk factors for cardiometabolic and hematological diseases and provide additional functional insights with the identification of potentially novel biological targets.
American Journal of Respiratory Cell and Molecular Biology | 2016
Gerard W. Dougherty; Niki T. Loges; Judith A. Klinkenbusch; Heike Olbrich; Petra Pennekamp; Tabea Menchen; Johanna Raidt; Julia Wallmeier; Claudius Werner; Cordula Westermann; Christian Ruckert; Virginia Mirra; Rim Hjeij; Yasin Memari; Richard Durbin; Anja Kolb-Kokocinski; Kavita Praveen; Mohammad Amin Kashef; Sara Kashef; Fardin Eghtedari; Karsten Häffner; Pekka Valmari; György Baktai; Micha Aviram; Lea Bentur; Israel Amirav; Erica E. Davis; Nicholas Katsanis; Martina Brueckner; Artem Shaposhnykov
Primary ciliary dyskinesia (PCD) is a recessively inherited disease that leads to chronic respiratory disorders owing to impaired mucociliary clearance. Conventional transmission electron microscopy (TEM) is a diagnostic standard to identify ultrastructural defects in respiratory cilia but is not useful in approximately 30% of PCD cases, which have normal ciliary ultrastructure. DNAH11 mutations are a common cause of PCD with normal ciliary ultrastructure and hyperkinetic ciliary beating, but its pathophysiology remains poorly understood. We therefore characterized DNAH11 in human respiratory cilia by immunofluorescence microscopy (IFM) in the context of PCD. We used whole-exome and targeted next-generation sequence analysis as well as Sanger sequencing to identify and confirm eight novel loss-of-function DNAH11 mutations. We designed and validated a monoclonal antibody specific to DNAH11 and performed high-resolution IFM of both control and PCD-affected human respiratory cells, as well as samples from green fluorescent protein (GFP)-left-right dynein mice, to determine the ciliary localization of DNAH11. IFM analysis demonstrated native DNAH11 localization in only the proximal region of wild-type human respiratory cilia and loss of DNAH11 in individuals with PCD with certain loss-of-function DNAH11 mutations. GFP-left-right dynein mice confirmed proximal DNAH11 localization in tracheal cilia. DNAH11 retained proximal localization in respiratory cilia of individuals with PCD with distinct ultrastructural defects, such as the absence of outer dynein arms (ODAs). TEM tomography detected a partial reduction of ODAs in DNAH11-deficient cilia. DNAH11 mutations result in a subtle ODA defect in only the proximal region of respiratory cilia, which is detectable by IFM and TEM tomography.
American Journal of Human Genetics | 2016
Julia Wallmeier; Hidetaka Shiratori; Gerard W. Dougherty; Christine Edelbusch; Rim Hjeij; Niki T. Loges; Tabea Menchen; Heike Olbrich; Petra Pennekamp; Johanna Raidt; Claudius Werner; Katsura Minegishi; Kyosuke Shinohara; Yasuko Asai; Katsuyoshi Takaoka; Chanjae Lee; Matthias Griese; Yasin Memari; Richard Durbin; Anja Kolb-Kokocinski; Sascha Sauer; John B. Wallingford; Hiroshi Hamada; Heymut Omran
Multiprotein complexes referred to as outer dynein arms (ODAs) develop the main mechanical force to generate the ciliary and flagellar beat. ODA defects are the most common cause of primary ciliary dyskinesia (PCD), a congenital disorder of ciliary beating, characterized by recurrent infections of the upper and lower airways, as well as by progressive lung failure and randomization of left-right body asymmetry. Using a whole-exome sequencing approach, we identified recessive loss-of-function mutations within TTC25 in three individuals from two unrelated families affected by PCD. Mice generated by CRISPR/Cas9 technology and carrying a deletion of exons 2 and 3 in Ttc25 presented with laterality defects. Consistently, we observed immotile nodal cilia and missing leftward flow via particle image velocimetry. Furthermore, transmission electron microscopy (TEM) analysis in TTC25-deficient mice revealed an absence of ODAs. Consistent with our findings in mice, we were able to show loss of the ciliary ODAs in humans via TEM and immunofluorescence (IF) analyses. Additionally, IF analyses revealed an absence of the ODA docking complex (ODA-DC), along with its known components CCDC114, CCDC151, and ARMC4. Co-immunoprecipitation revealed interaction between the ODA-DC component CCDC114 and TTC25. Thus, here we report TTC25 as a new member of the ODA-DC machinery in humans and mice.